Brief: Allergy Therapeutics Announces Satisfaction Of FDI Clearance Conditions
Sept 22 (Reuters) - Allergy Therapeutics PLC AGY.L :
* ALLERGY THERAPEUTICS - SATISFACTION OF FDI CLEARANCE
CONDITIONS
* ALLERGY THERAPEUTICS - ALL FDI CLEARANCE CONDITIONS HAVE
BEEN
SATISFIED IN RELATION TO EQUITY FINANCING PREVIOUSLY ANNOUNCED
* ALLERGY THERAPEUTICS PLC - EQUITY FINANCING WILL RAISE
GROSS
PROCEEDS OF £40.75 MILLION
Source text for Eikon: ID:nRSV2874Na
Further company coverage: AGY.L
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Allergy Therapeutics
See all newsRCS - Allergy Therapeutics - Allergy Therapeutics to present at EAACI 2026
UK's Allergy Therapeutics H1 revenue rises 7%, operating loss widens
Brief: Allergy Therapeutics H1 Pretax Profit GBP -19.33 Million
Allergy Therapeutics - Interim Results for six months ended 31 Dec 2025
Allergy Therapeutics - PDMR Dealings & Shareholding Update